Turkey coronavirus (TCoV) is a Gammacoronavirus causing acute contagious enteritis in young turkeys, leading to impaired growth, low feed conversion, and increased mortality. The TCoV infections, in association/combination with other enteropathogenic viruses, bacteria & protozoa, are associated with poult enteritis-mortality syndrome (PEMS) in turkeys of 1-4 weeks age. In this review, classification & genotyping of TCoV, the implications of its recombination, and challenges to develop efficient vaccines against it are discussed. Though TCoV is monophyletic with infectious bronchitis virus (IBV) with a sequence similarity of ≥86, however a classification scheme gathering all avian coronaviruses (ACoVs) is not established. Based on the N gene, ACoVs are classified into five clades. Clades 1 & 2 (chickens), Clade 3 (pigeon) Clade 4 (duck), and Clade 5 (goose). The Spike (S) gene of ACoVs has shown exceptional lability of being easily switched with multiple recombination events suggesting that TCoV may be an IBV recombinant. Recombination events altered the pathogenicity, host specificity, and tissue tropism of TCoVs. Attempts to develop attenuated, inactivated, DNA, and virus-vectored vaccines are ongoing. Experimentally, the attenuated TCoV strains induced strong humoral and cellular immune responses and completely protected against the homologous challenge but not heterologous TCoV challenge. Meanwhile, genetically engineered vaccines, either DNA or virus vectored vaccines, are limited with either late induction of a protective immune response and/or inability of the elicited antibody to neutralize virus infection and protect against virus challenge. Future research should focus on improving vaccine efficiency against TCoVs by developing more immunogenic vaccines, determining the appropriate dosing regimens, and include potent adjuvants

In the United States, non-typhoidal Salmonella causes over one million food-borne infections every year and turkey meat contaminated with Salmonella has been associated from the farm to the processing plant. These outbreaks emphasize efforts on decreasing and preventing human illness associated with live poultry contact through comprehensive interventions from farm-to-fork levels. This review article revises the role of the turkey upper respiratory tract, which is now known to play a crucial role in colonization and as a source of contamination, for this remarkable bacterium that has co-evolved to infect plants and animals. Because agriculture represents over 60 % of the economy of the state of Arkansas, the mission of our laboratory over the last 21 years has been to evaluate and develop applied research to help reduce the incidence of Salmonella spp. from commercial turkey operations. A summary of the published research is presented.

The aim of this study was to evaluate the anti-helminthic effect of a commercial formulation Bioverm® (Duddingtonia flagrans) in 28 sheep naturally infected with gastrointestinal nematodes. Animals were classified into two groups: G1 (n=14) treated with nematophagous fungi and G2 (n=14) untreated control. The efficacy of the anti-helminthic drug was assessed based on the egg count per gram of feces (EPG) of strongyles, larval culture, hemogram, leukogram, plasma protein levels, mucosal coloration using the FAMACHA© method, animals body weight, and evaluating the ocular mucosa for the FAMACHA© anemia guide were performed at days 0, 30, 60, 90, 120, 150, and 180. Additionally, the nematode larvae were quantified in the dry matter of the pastures of both groups. Results showed that the EPG was significantly decreased in animals receiving nematophagous fungi from D30 until the experiment end. The most common nematode genus was Haemonchus (63%), followed by Cooperia (23%) and Trichostrongylus (15%). Based on the fecal egg count reduction test (FECRT), treated animals showed a reduction of fecal egg count of 58.9%, 8.6%, 92.8%, 96.4%, and 96.2%, at D30, D60, D90, D120, and D180, respectively. The absolute values of red blood cells and leukocytes were significantly increased at D60 and D90, respectively, in the treated animals. A significant weight gain was observed in the treated ewes at the end of the experiment; however, there was no correlation between the EPGs values and hematocrit with the FAMACHA© degrees of animals in both experimental groups. The mean EPG of both groups and the number of infectious larvae in the pastures were not directly proportional. In conclusion, nematophagous fungi contributed to decreased parasitic load in sheep, and consequently, improve animal performance; they can be a suitable alternative to reduce problems associated with nematode infections.

Both of Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) infections are the most common Mycoplasma infection in domestic poultry. The disease is associated with economic losses in poultry. MG and MS are commonly spread within chicken (Gallus gallus domesticus) and turkey (Meleagris gallopavo domesticus) flocks; however, they are frequently isolated from quails (Coturnix coturnix) and several avian species. Diagnosis of MG or MS infections is confirmed by isolating the organism in a cell-free medium or directly detecting its DNA in infected tissues or swab samples. Serological tests are also widely used for diagnosis. However, advances in molecular biology represented a rapid and sensitive alternative to the traditional culture methods requiring specialized techniques and sophisticated reagents. Several Mycoplasma molecular diagnostic tests are implemented: including polymerase chain reaction (PCR), Random Amplified Polymorphic DNA (RAPD), arbitrary primed polymerase chain reactions (AP‐PCR), and Multiplex real-time polymerase chain reaction (Multiplex MGMS). Current control practices against Mycoplasma infection include intense biosecurity, biosurveillance, medication, and vaccination. However, the egg-borne nature of avian Mycoplasma infection complicates controlling the infection. This review focuses on the advances in diagnosis and control of avian Mycoplasma infection, especially MG and MS infections.

Given the high importance of animal uses for human being, avoidance of contact with animals is far from straightforward even if there is a risk of zoonotic diseases. Animal products or byproducts are essential source of food for human. Also, there are large numbers of companion animals worldwide which are important for the soundness of mental health for the owners. Understanding of the disease in animals is of paramount importance to control and prevent transmission to human. Zoonotic protozoan parasites, including malaria, babesiosis, trypanosomiasis, toxoplasmosis and cryptosporidiosis, can cause severe infections to human and some of them can drastically affect both economy and society. Impacts of such infections are aggravated when asymptomatic animals being in contact with susceptible individuals including infants, pregnant women or immunocompromised people. Malaria, babesiosis and trypanosomiasis are vector-borne diseases that cause hemolytic anemia and high fever. Toxoplasmosis is a congenitally transmitted infection characterized by abortion and congenital abnormalities in infected persons and animals. Cryptosporidiosis is a highly contagious disease affecting human and various animal species and diarrhea is the main clinical form. These infections are globally distributed and affect various demographics. However, awareness of these often neglected diseases in almost all countries and communities are required for protecting animals, owners and customers. Thus, this review is aimed to provide the recent and current knowledge on transmission, epidemiology and control of some protozoan diseases of zoonotic importance.

The aim of this study was to evaluate the occurrence of Shiga toxin (stx)-producing Escherichia coli (STEC) in diarrheic newborn calves, as well as the resistance profile of this microorganism against antimicrobials routinely used in veterinary therapy. The antimicrobial profile of Eugenia uniflora against E. coli clinical isolates was also analyzed. Specimens from the recto-anal junction mucosa were investigated by using chromogenic medium and identification of E. coli was done using microbiological methods (Gram staining, indole test, methyl red test, Voges-Proskauer test, citrate test, urease test, and hydrogen sulfide test). The stx1 and stx2 genes corresponding to the STEC pathotype were evaluated by using polymerase chain reaction and electrophoresis. The susceptibility profile to antimicrobial agents commonly used in veterinary therapeutic practice and the antimicrobial effect of lyophilized hydroalcoholic extract of E. uniflora L. leaves against E. coli clinical isolates were evaluated by disk diffusion and microdilution methods. Shiga toxin-positive E. coli was identified in 45% of diarrheic newborn calves (stx1 = 23.2%, stx2 = 4.0%, stx1 + stx2 = 18.2%). The frequency of stx-positive E. coli in the bacterial population was equal to 17.0% (168/990 clinical isolates): 97 (9.8%) stx1-positive E. coli, 12 (1.2%) stx2-positive E. coli, and 59 (6.0%) stx1 + stx2-positive E. coli isolates. All stx-positive E. coli analyzed showed resistance to multiple drugs, that is, from 4 to 10 antimicrobials per clinical isolate (streptomycin, tetracycline, cephalothin, ampicillin, sulfamethoxazole + trimethoprim, nitrofurantoin and nalidixic acid, ciprofloxacin, gentamicin, and chloramphenicol). Effective management measures should be implemented, including clinical and laboratory monitoring, in order to promote animal and worker health and welfare, prevent and control the spread of diseases, and ensure effective treatment of infectious diseases. The E. uniflora L. leaves showed inhibition of microbial growth based on the diameter of halos, ranging from 7.9 to 8.0 mm and 9.9 to 10.1 mm for concentrations of 50 and 150 mg/mL, respectively. This plant displayed bacteriostatic action and a minimum inhibitory concentration of 12.5 mg/mL for all clinical isolates. Its clinical or synergistic effects with antimicrobial agents must be determined from clinical and preclinical trials.

Calf diarrhea leads to substantial economic losses in the livestock industry worldwide due to medical treatment costs, retarded growth performance, and even death. The objective of this study was to investigate changes in serum protein profiles and acute phase proteins in calves with diarrhea and identify the association between these changes and diarrhea. A total of 185 Korean beef calves were used and divided into 3 groups by age: 1 to 10 days (n = 46), 11 to 20 days (n = 65), and 21 to 30 days (n = 74). Blood and fecal samples were collected from each calf. Serum concentrations of total protein, protein fractions (albumin, α1-globulin, α2-globulin, β-globulin, and γ-globulin), haptoglobin (Hp), and serum amyloid A (SAA) were analyzed. Compared to calves without diarrhea, calves with diarrhea had significantly lower albumin concentrations at 11 to 20 days and 21 to 30 days of age (P = 0.017 and P = 0.000, respectively) and significantly higher α1-globulin fractions at 21 to 30 days of age (P = 0.01). Interestingly, α2-globulin fractions were significantly higher in diarrheic calves in all age groups, whereas γ-globulin fractions were significantly lower in calves with diarrhea aged 1 to 10 days, compared with normal animals. In calves with diarrhea, the concentration of Hp was significantly higher, whereas SAA levels were not different between normal and diarrheic calves. In addition, a positive correlation was found between α2-globulin and Hp (P = 0.0004). Taken together, these results provide useful information about the use of serum protein profiles and Hp as prognostic and diagnostic markers for animal health status.

OBJECTIVE To investigate the effects of recombinant equine IL-1β on function of equine endothelial colony-forming cells (ECFCs) in vitro. SAMPLE ECFCs derived from peripheral blood samples of 3 healthy adult geldings. PROCEDURES Function testing was performed to assess in vitro wound healing, tubule formation, cell adhesion, and uptake of 1,1′-dioctadecyl-3,3,3′,3′ tetramethylindocarbocyanine perchlorate–labeled acetylated low-density lipoprotein (DiI-Ac-LDL) by cultured ECFCs. Cell proliferation was determined by 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide assay. Effects on function test results of different concentrations and exposure times of recombinant equine IL-1β were assessed. RESULTS Challenge of cultured ECFCs with IL-1β for 48 hours inhibited tubule formation. Continuous challenge (54 hours) with IL-1β in the wound healing assay reduced gap closure. The IL-1β exposure did not significantly affect ECFC adhesion, DiI-Ac-LDL uptake, or ECFC proliferation. CONCLUSIONS AND CLINICAL RELEVANCE These results suggested a role for IL-1β in the inhibition of ECFC function in vitro. Functional changes in ECFCs following challenge with IL-1β did not appear to be due to changes in cell proliferative capacity. These findings have implications for designing microenvironments for and optimizing therapeutic effects of ECFCs used to treat ischemic diseases in horses.

OBJECTIVE To determine the safety and pharmacokinetics of various doses of plant-derived cannabidiol (CBD) versus placebo following repeated oral administration. ANIMALS 20 healthy adult Beagles. PROCEDURES In a randomized, blinded, placebo-controlled trial, dogs were randomized to 5 groups balanced in body weight and sex (n = 4 dogs/group) and received a CBD (1, 2, 4, or 12 mg/kg; from cannabis extract) or placebo oil formulation PO once daily for 28 days. Outcome variables were assessed through daily health observations, veterinary examinations, CBC, and serum biochemical analysis. Blood samples were collected at various time points to estimate 24-hour pharmacokinetic profiles of CBD and selected metabolites (7-carboxy-CBD and 7-hydroxy-CBD). RESULTS Repeated CBD administration was well tolerated by dogs, with no clinically important changes in measured safety outcomes. Veterinary examinations revealed no clinically important abnormal findings. Adverse events were mild in severity. Relative to placebo administration, CBD administration at 12 mg/kg/d resulted in more gastrointestinal adverse events (mainly hypersalivation) and significantly higher serum alkaline phosphatase activity. Total systemic exposure to CBD increased on a dose-dependent basis following both acute (first dose) and chronic (28 days) administration. Within each CBD dose group, repeated administration increased total systemic exposure to CBD 1.6- to 3.3-fold. The 24-hour trough plasma CBD concentrations were also dose dependent, with a steady state reached following 2 weeks of administration. CONCLUSIONS AND CLINICAL RELEVANCE Repeated, daily oral administration of the CBD formulation led to dose-dependent increases in total systemic exposure to CBD and 24-hour trough plasma concentrations in healthy dogs. These findings could help guide dose selection.